|
 |
|
|
| |
Other drugs |
|
|
MILGAMMA
Substance (drage): 250 mcg cyancobalaminum, 50 mg benfotiaminum.
Substance (injection): 1 mg cyancobalaminum, 100 mg pyridoxinum chloratim, 100 mg thiaminium chloratum, 20 mg lidocainium chloratum / 2 ml
Substance (capsules): 250 mcg cyancobalaminum, 40 mg benfotiaminum, 90 mg pyridoxinium chloratum
|
 |
|
Dosage
|
Packing
|
Price
|
Pay now
|
|
mg
|
50 drage
|
USD 39.00
|
|
|
mg
|
100 drage
|
USD 69.00
|
|
|
mg
|
500 drage
|
USD 247.00
|
|
|
2 ml
|
10 amp
|
USD 26.00
|
|
|
2 ml
|
30 amp
|
USD 69.00
|
|
|
mg
|
20 caps
|
USD 0.00
|
|
|
mg
|
50 caps
|
USD 37.00
|
|
|
mg
|
100 caps
|
USD 76.00
|
|
|
mg
|
500 caps
|
USD 247.00
|
|
|
|
|
ZYRTEC (Cetirizine)
Manufacturer: UCB PHARMA (Belgium)
|
 |
Zyrtec (Cetirizine 10mg) is the only leading prescription antihistamine
approved to treat both year-round indoor and outdoor allergies, chronic
itching and hives in adults and children as young as 2 years. Zyrtec
provides effective relief for itchy, runny nose; sneezing; itchy, red,
and watery eyes; and postnasal drip. Zyrtec also reduces chronic hives
and their associated itching.
Dosage |
Packing |
Price |
Pay now |
10 mg |
20 tab |
USD 24.00 |
|
10 mg |
30 tab |
USD 35.00 |
|
|
|
|
PANTOCRIN (Velvet Antler Liquid Extract)
|
 |
Extracts from antlers of wild reindeer have: a powerful anti-aging action,
enhance libido and sexual activity, heighten mental alertness, increase muscle
tone, lower recovery time after exertion. Effective remedy to cope with
arthritis and polyarthritis. The drug possesses high antioxidant, anti-stress,
and immunomodulation activity. It activates the DNA repairing processes and
contributes to gene stability.
Dosage |
Packing |
Price |
Pay now |
50 ml |
1 bottle |
USD 35.00 |
|
Mumio (Mumijo)
|
 |
MUMIO is a versatile, naturally occurring biological regulator, possessing
a wide spectrum of health uses. It exerts a favorable effect on metabolic
processes and on the human immune system, restoring decreased functions
of the body. MUMIO is a unique biologically-active substance with striking
healing effects and protective influence on the human body. It long been
used in Asian and Russian traditional medicine, and is still used today
for medical purposes.
Dosage |
Packing |
Price |
Pay now |
|
150 mg
|
60 caps
|
USD 15.00 |
|
|
|
|
ACYCLOVIR (Anti-viral drug)
|
|
|
Dosage
|
Packing
|
Price
|
Pay now
|
|
200 mg
|
50 tab
|
USD 66.00
|
|
|
200 mg
|
100 tab
|
USD 130.00
|
|
|
200 mg
|
200 tab
|
USD 246.00
|
|
|
400 mg
|
70 tab
|
USD 147.00
|
|
|
400 mg
|
140 tab
|
USD 275.00
|
|
|
800 mg
|
70 tab
|
USD 211.00
|
|
|
800 mg
|
140 tab
|
USD 409.00
|
|
|
Zovirax cream 5%, 2g
|
USD 13.00
|
|
|
Zovirax cream 5%, 6g
|
USD 37.00
|
|
|
|
|
|
CAMPRAL
Generic name: acamprosate
Product Brand Name: Campral
Product Manufacturer: Merck, France
|
|
|
Dosage
|
Packing
|
Price
|
Pay now
|
|
333 mg
|
84tab
|
USD 112.00
|
|
|
333 mg
|
168tab
|
USD 217.00
|
|
|
Campral helps to avoid alcohol dependence. It helps people who have already
stopped drinking alcohol keep from starting again. You must be alcohol-free
before taking Campral for it to work. You must also be prepared to follow a
complete alcohol treatment plan that includes mental and behavioral health counseling.
Campral is thought to work by restoring and regulating brain chemicals that
have been disrupted by long-term exposure to alcohol. Campral is not used for
any type of substance dependence other than alcohol.
|
|
|
COENZYME Q10
Generic Name: ubiquinone
Product Brand Name: CoEnzyme Q10 ® (CoQ10)
|
|
Dosage |
Packing |
Price |
Pay now |
10 mg CoQ10 3.5 mg vit. E |
20 caps |
USD 59.00 |
|
|
|
|
|
DITROPAN Urologic problems
Generic name: Oxybutynin
Manufacturer: Sanofi
|
|
Dosage |
Packing |
Price |
Pay now |
5 mg |
30 tab |
USD 42.00 |
|
5 mg |
90 tab |
USD 106.00 |
|
|
|
|
|
WELLBUTRIN - SR
Substance: Bupropion hydrochloride
Manufacturer: GlaxoSmithKline
|
|
Dosage |
Packing |
Price |
Pay now |
150 mg |
30 tab |
USD 45.00 |
|
|
|
 |
Research articles
on Anti-Aging drug |
|
| |
Oxybutynin
Mayo Clin Proc. 2003 Jun;78(6):687-95.
Prospective, randomized, double-blind study of the efficacy and tolerability
of the extended-release formulations of oxybutynin and tolterodine for overactive
bladder: results of the OPERA trial.
Diokno AC, Appell RA, Sand PK, Dmochowski RR, Gburek BM, Klimberg IW, Kell
SH; OPERA Study Group.
Department of Urology, William Beaumont Hospital, Royal Oak, Mich 48073,
USA.
OBJECTIVE: To compare the efficacy and tolerability of extended-release
formulations of oxybutynin chloride and tolterodine tartrate in women with
overactive bladder. PATIENTS AND METHODS: The OPERA (Overactive bladder:
Performance of Extended Release Agents) trial was a randomized, double-blind,
active-control study performed at 71 US study centers from November 21,
2000, to October 18,2001. Extended-release formulations of oxybutynin at
10 mg/d or tolterodine at 4 mg/d were given for 12 weeks to women with 21
to 60 urge urinary incontinence (UUI) episodes per week and an average of
10 or more voids per 24 hours. Episodes of UUI (primary end point), total
(urge and nonurge) incontinence, and micturition were recorded in 24-hour
urinary diaries at baseline and at weeks 2, 4, 8, and 12 and compared. Adverse
events were also evaluated. RESULTS: Improvements in weekly UUI episodes
were similar for the 790 women who received extended-release formulations
of oxybutynin (n = 391) or tolterodine (n = 399). Oxybutynin was significantly
more effective than tolterodine in reducing micturition frequency (P = .003),
and 23.0% of women taking oxybutynin reported no episodes of urinary incontinence
compared with 16.8% of women taking tolterodine (P = .03). Dry mouth, usually
mild, was more common with oxybutynin (P = .02). Adverse events were generally
mild and occurred at low rates, with both groups having similar discontinuation
of treatment due to adverse events. CONCLUSIONS: Reductions in weekly UUI
and total incontinence episodes were similar with extended-release formulations
of oxybutynin and tolterodine. In the oxybutynin group, micturition frequency
was significantly lower, and the percentage of women reporting no urinary
incontinence episodes was significantly higher compared with the tolterodine
group. Dry mouth was more common with oxybutynin, but tolerability was otherwise
comparable, including adverse events involving the central nervous system.
|
Curr Opin Allergy Clin Immunol.
2002 Feb;2(1):53-9.
Are antihistamines useful in managing asthma?
Wilson AM.
Asthma and Allergy Research Group, Department of Clinical Pharmacology and
Therapeutics, Ninewells Hospital and Medical School, University of Dundee,
Dundee DD1 9SY, Scotland, UK.
There continues to be a great deal of interest in the anti-asthmatic
role of antihistamines. Antihistamines have recently been shown to have
anti-inflammatory properties that are more extensive than simply the blocking
of histamine receptors. For example, new evidence suggests that the suppression
of cell adhesion molecule expression occurs with these drugs. The anti-inflammatory
and anti-asthmatic effects of antihistamines have been evaluated in patients
with both allergic asthma and rhinitis, given the established association
between allergic inflammation of the upper and lower airways, with evidence
to suggest that antihistamines have clinically relevant anti-asthmatic
properties. As well as conferring benefits in asthma symptom control and
the measurement of lung function, studies assessing the effect of histamine
receptor antagonists on bronchial hyperresponsiveness suggest that there
is bronchoprotection during both methacholine and mannitol challenges.
Recently, there has also been considerable interest in the effect of combining
an antihistamine with a leukotriene receptor antagonist. This combination
has an anti-asthmatic effect that is greater than that of either drug
given alone and may be comparable to inhaled corticosteroid therapy.
|
| | |
In general most countries have a policy which allows the importation
of up to 3 months supply of a given medication without the need
for a prescription, as long as it is for personal use. We give information
about import conditions for different countries on our page: Shipping;
but national policies are subject to change and we cannot guarantee
that this information will always be absolutely correct. You can obtain
information on the applicable importation policy by contacting your
countrys Customs authority. In 99% of cases we have experienced
no problems with secure worldwide delivery to our customers.
For safety reasons we may ship orders in separate shipments with a
timelag of 2-7 days between part-shipments.
We DO NOT supply medications generally classed as controlled substances.
|
|
|